Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Hyperforin (CAS 11079-53-1)

0.0(0)
Write a reviewAsk a question

Datasheets
Alternate Names:
hyperforin hiperforina hyperforine CHEBI:5834
CAS Number:
11079-53-1
Molecular Weight:
536.81
Molecular Formula:
C35H52O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

QUICK LINKS

Hyperforin inhibits the uptake of the monoamine neurotransmitters serotonin, dopamine, noradrenaline, and GABA. The specific mechanism of serotonin uptake inhibition is correlated with Hyperforin-induced elevation of intracellular Na+ levels. AMPA induced currents were shown to be competitively and incompletely inhibited by Hyperforin, while NMDA receptor-activated ionic conductance was completely and uncompetitively inhibited. Hyperforin is described to present neuroprotective effects, demonstrating the induction of amyloid-beta aggregate disassembly, improvement of spatial memory, and decrease of astrogliosis and microglia activation. The action of inducible nitric oxide synthase (iNOS) was modulated by Hyperforin, demonstrating reduced NO production through suppression of iNOS on the mRNA and protein levels, further correlating to the neuroprotection generated by this compound. Hyperforin demonstrates selective activation of the transient receptor potential channel TRPC6. Activation of the pregnane X receptor by Hyperforin produces induction of cytochrome p450 3A4 monooxygenase expression, promoting oxidation metabolism activity of this enzyme.


Hyperforin (CAS 11079-53-1) References

  1. Mechanistic insights into the antileukemic activity of hyperforin.  |  Billard, C., et al. 2013. Curr Cancer Drug Targets. 13: 1-10. PMID: 22924417
  2. Anticancer and Antibacterial Activity of Hyperforin and Its Derivatives.  |  Pia Schiavone, BI., et al. 2014. Anticancer Agents Med Chem. 14: 1397-1401. PMID: 25173557
  3. Biotechnological production of hyperforin for pharmaceutical formulation.  |  Gaid, M., et al. 2018. Eur J Pharm Biopharm. 126: 10-26. PMID: 28377273
  4. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.  |  Chrubasik-Hausmann, S., et al. 2019. J Pharm Pharmacol. 71: 129-138. PMID: 29411879
  5. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.  |  Zhang, S., et al. 2021. Front Immunol. 12: 635076. PMID: 34025642
  6. Targeting the biological activity and biosynthesis of hyperforin: a mini-review.  |  Liu, S., et al. 2022. Chin J Nat Med. 20: 721-728. PMID: 36307194
  7. Hyperforin: A natural lead compound with multiple pharmacological activities.  |  Li, XX., et al. 2023. Phytochemistry. 206: 113526. PMID: 36442576
  8. Hyperforin Suppresses Oncogenic Kinases and Induces Apoptosis in Colorectal Cancer Cells.  |  Hsu, LC., et al. 2023. In Vivo. 37: 182-189. PMID: 36593022
  9. Hyperforin regulates renal fibrosis via targeting the PI3K-AKT/ICAM1 axis.  |  Yang, S., et al. 2023. Cell Signal. 108: 110691. PMID: 37116554
  10. Hyperforin ameliorates neuroinflammation and white matter lesions by regulating microglial VEGFR2 /SRC pathway in vascular cognitive impairment mice.  |  Gao, X., et al. 2024. CNS Neurosci Ther. 30: e14666. PMID: 38468126

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Hyperforin, 250 µg

sc-507549
250 µg
$420.00